INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsHighNeutral
Announced Tue, 4 Nov · 18:05 IST

Ind-Swift Laboratories Limited has informed the Exchange regarding 'UPDATE ON LISTING OF SHARES ALLOTTED PURSUANT TO THE SCHEME OF AMALGAMATION'.

Listed Co AcquisitionStrategic Transactions View source PDF

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Laboratories Limited is updating stakeholders on the listing status of equity shares allotted to shareholders of Ind-Swift Limited under an approved Scheme of Amalgamation. The shares were allotted on August 25, 2025, and listing applications were filed with NSE and BSE on September 12, 2025. NSE has already granted listing approval on October 10, 2025, while BSE approval is awaited and expected shortly. Once both approvals are received, shares will be credited to shareholders' demat accounts, after which trading approval will be sought. The company is in regular communication with BSE to expedite the process.

Likely market impact

Existing shareholders of Ind-Swift Limited should expect the newly allotted shares of Ind-Swift Laboratories to be credited to their demat accounts soon, enabling them to trade once BSE approval and trading permission are obtained. This is a procedural update, not a new business event, so immediate stock price impact is unlikely.